Spanish Pharmaceuticals & Biotech High Growth Potential Companies

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Labiana Health

Market Cap: €20.0m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

Oryzon Genomics

Market Cap: €176.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.

Laboratorio Reig Jofre

Market Cap: €217.0m

A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics.

Almirall

Market Cap: €2.0b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Grifols

Market Cap: €4.8b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.5b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.